Effect of vitamin E deficiency on rat brain monoamine metabolism

Neurochemical Research

Volumn 24, Issue 10, 1999, Pages 1307-1311

  Adachi, Koshin ^a   Izumi, Masayuki ^a   Mitsuma, Terunori ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Dopamine; Monoamine metabolism; Parkinson's disease; Serotonin; Tryptophan hydroxylase activity; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; BRAIN MONOAMINE; DOPAMINE; SEROTONIN; TRYPTOPHAN; TRYPTOPHAN HYDROXYLASE; TYROSINE;

ALPHA TOCOPHEROL DEFICIENCY; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BIOGENIC MONOAMINES; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROCHEMISTRY; MALE; RATS; RATS, WISTAR; TRYPTOPHAN HYDROXYLASE; TYROSINE 3-MONOOXYGENASE; VITAMIN E; VITAMIN E DEFICIENCY;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0032824716     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020937409855     Document Type: Article

References (31)

1. Götz, M. R. E., Freyberger, A., and Riederer, P. 1990. Oxidative stress: a role in the pathogenesis of Parkinson's disease. J. Neural. Transm., 29 (suppl):241-249.
2. Marsden, C. D. 1990. Parkinson's disease. Lancet 1:948-952.
3. Dexter, D. T., Carter, C., Wells, F. R., and et al. 1989. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem., 52:381-389.
4. Kilinc, A., Yalcin, A. S., Yalcin, D., and et al. 1988. Increased erythrocyte susceptibility to lipid peroxidation in human Parkinson's disease. Neurosci. Lett., 87:307-310.
5. Pall, H. S., Williams, A. C., Blake, D. R., and et al. 1986. Lipid peroxidation and Parkinson's disease (letter). Lancet, 1:870-871.
6. Smith, M. R., Sandy, M. S., and Di Monte, D. 1987. Free radicals, lipid peroxidation and Parkinson's diseas (letter). Lancet 1:38.
7. Poirier, J., and Barbeau, A. 1987. Erythrocyte antioxidant activity in human patients with Parkinson's disease. Neurosci Lett., 75:345-348.
8. Ambani, L. M., Van Woert, M. N., and Murphy, S. 1975. Brain peroxidase and catalase in Parkinson's disease. Arch. Neurol., 32:114-118.
9. Kish, S. J., Morito, C., and Hornykiewicz, O. 1985. Glutathion peroxidase activity in Parkinson's disease. Neurosci. Lett., 58: 343-346.
10. Perry, T.L., Godin, D.V., and Hansen, S. 1982. Parkinson's disease: a disorder due to nigral glutathion deficiency? Neurosci., Lett. 33:305-310.
11. Riederer, P., Sofic, E., Rausch, W. D., and et al. 1989. Transition metals, ferritine, glutathion, and ascorbic acid in parkinsonian brains. J. Neurochem., 52:515-520.
12. Friedrich, W. 1988. Vitamin E. Pages 219-286, in Friedrich, W. (ed), Vitamins, Walter de Gruyter, Berlin.
13. Grimes, J. D., Hassan, M.N., and Thakar, J. 1987. Antioxidant therapy in Parkinson's disease. Can. J. Neurol. Sci., 14 (supple): 483-487.
14. Muller, D. P. R., Lyond, J.K., and Wolff, O. H. 1983. Vitamin E and neurological function. Lancet, 1:225-228.
15. Halliwall, B., and Gutteridge, J. M. C. 1990. The antioxidants of human extracellular fluids. Arch. Biochem. Biophys., 280:1-8.
16. Driskell, W.J., Neese, J.W., Bryant, C.C., and et al. 1982. Measurement of vitamin A and vitamin E in human serum by high performance liquid chromatography. J. Chromatogr., 231: 439-444.
17. Siuciak, J. A., Gamache, P. H., and Dubocovich, M. L. 1992. Monoamines and their precursors and metabolites in the chicken brain, pineal and retina: regional distribution and day/night variations. J. Neurochem., 58(2):722-729.
18. Paxinos, G., and Watson, C. 1986. The rat brain in stereotaxic coordinates, in Paxinos G, and Watson C (eds), Academic Press, Australia.
19. Fujisawa, H., and Nakata, H. 1987. Tryptophan 5-monooxygenase from rat brain stem. Methods in Enzymology., 142:83-86.
20. Nagatsu, T., Oka, K., and Kato, T. 1979. Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography. J. Chromatogr., 163:247-252.
21. Golbe, L. I., Farrell, T. M., and Davis, P. H. 1988. Case-control study of early life dietary factors in Parkinson's disease. Arch. Neurol., 45:1350-1353.
22. Golbe, L. I., Farrell, T. M., and Davis, P. H. 1990. Follow-up study on early life protective and risk factors in Parkinson's disease. Mov. Disord., 5:66-70.
23. Férnandez-Calle, P., Molina, J. A., Jiménez-Jiménez, F. J., and et al. 1992. Serum levels of alpha-tocopherol (vitamin E) in Parkinson's disease. Neurology, 42:1064-1066.
24. Fahn, S. 1989. The endogeneous toxin hypothesis of the etiology of Parkinson's disease and a pilot trial of high dosage antioxidants in an attempt to slow the progression of the illness. Ann. NY. Acad. Sci., 570:186-196.
25. Perry, T. L., Yong, R. M., Clavier, K., and et al. 1985. Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine by four different antioxidants in the mouse. Neurosci. Lett., 63:56-60.
26. Yong, W. W, Perry, T. L., and Krisman, A. A. 1986. Deletion of glutathione in brain stem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment. Neurosci. Lett., 63:56-60.
27. Martinovits, G., Melamed, E., Cohen, O., and et al. 1986. Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine (MPTP). Neurosci. Lett., 69:192-197.
28. Perry, T. L., Yong, V. W., Hansen, S., and et al. 1987. α-Tocophenol and β-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine. J. Neurol. Sci., 81:321-331.
29. Odunze, I. N., Klaidman, L. K., and Adams, J. D. Jr. 1990. MPTP toxicity in the mouse brain and vitamin E. Neurosci. Lett., 108:346-349.
30. Adams, J. D. Jr., Odunze, I. N., and Sevanian, A. 1990. Induction by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of lipid peroxidation in vivo in vitamin E deficient mice. Biochem. Pharmacol., 39:R5-R8.
31. MacEvilly, C., and Muller, D. P. R. 1996. Lipid peroxidation in neural tissues and fractions from vitamin E-deficient rats. Free. Radic. Biol. Med., 20(5):639-648.